
    
      Trial arm A (DCaT-RNA) = Experimental intervention: Patients in arm A receive 8 vaccinations
      over a period of 2 years consisting of autologous, mature, monocyte-derived Dendritic Cells
      loaded with autologous tumor RNA (20 mio DC per vaccination); cells are given via intravenous
      infusions; vaccinations are followed by a 1 year observation (staging every 3 months)

      Trial arm B (Observation) = Control: Patients in arm B receive standard care (observation
      only with staging every 3 months)
    
  